42 U.S. Code § 2142 - Domestic medical isotope production
prev | next
(a) The Commission may issue a license, or grant an amendment to an existing license, for the use in the United States of highly enriched uranium as a target for medical isotope production in a nuclear reactor, only if, in addition to any other requirement of this chapter—
(1) the Commission determines that—
(b) As used in this section—
(1) the term “alternative medical isotope production target” means a nuclear reactor target which is enriched to less than 20 percent of the isotope U–235;
(2) a target “can be used” in a nuclear research or test reactor if—
(A) the target has been qualified by the Reduced Enrichment Research and Test Reactor Program of the Department of Energy; and
(3) the term “highly enriched uranium” means uranium enriched to 20 percent or more in the isotope U–235; and
Source(Aug. 1, 1946, ch. 724, title I, § 112, as added Pub. L. 112–239, div. C, title XXXI, § 3176(a),Jan. 2, 2013, 126 Stat. 2215; Pub. L. 113–66, div. C, title XXXI, § 3144,Dec. 26, 2013, 127 Stat. 1071.)
References in Text
This chapter, referred to in subsec. (a), was in the original “this Act”, meaning act Aug. 1, 1946, ch. 724, as added by act Aug. 30, 1954, ch. 1073, § 1,68 Stat. 919, known as the Atomic Energy Act of 1954, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 2011 of this title and Tables.
2013—Pub. L. 113–66inserted enumerator and section catchline.
LII has no control over and does not endorse any external Internet site that contains links to or references LII.